New approaches for the management of atrial fibrillation: Role of ablation of atrial flutter

Journal of Cardiovascular Electrophysiology

Volumn 10, Issue 9, 1999, Pages 1188-1191

  Feld, Gregory K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; QUINIDINE;

CATHETER ABLATION; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART PACING; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0032826641     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1999.tb00294.x     Document Type: Note

References (41)

1. Furberg CD, Bruce MP, Manolio TA, et al, for the CHS Collaborative Research Group: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-241.
2. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy for antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
3. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-48.
4. Grogan M, Smith HC, Gersh BJ, et al: Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-1573.
5. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM Investigators: AFFIRM (atrial fibrillation follow-up investigation of rhythm management) - The AFFIRM study design. Am J Cardiol 1997;79:1198-1202.
6. Juul-Moller S, Edvardsson N, Rehnqvist-Ahlberg N: Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990;82:1932-1939.
7. Gosselink TM, Crijns HJGM, Van Gelder IC, et al: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992;267:3289-3293.
8. Anderson JL, Gilbert EM, Alpert BL, et al: Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multi-center, double-blind crossover study of flecainide and placebo with transtelephonic monitoring. Circulation 1989;80:1557-1570.
9. Cox JL, Boineau JP, Schuessler RB, et al: Five year experience with Maze procedure for atrial fibrillation. Ann Thorac Surg 1993;56:814-824.
10. Feld GK: Radiofrequency catheter ablation versus modification of the AV node for control of rapid ventricular response in atrial fibrillation. J Cardiovasc Electro-physiol 1995;6:217-228.
11. Delfaut P, Saksena S, Prakash A, et al: Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998;32:1900-1908.
12. Lau CP, Tse HF, Lok NS, et al: Initial clinical experience with an implantable human atrial defibrillator. PACE 1997;20:220-225.
13. Haïssagnerre M, Jaïs P, Shah DC, et al: Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:1132-1144.
14. Garg A, Finneran W, Mollerus M, et al: Right atrial compartmentalization using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:763-771.
15. Feld GK, Chen PS, Nicod P, et al: Possible atrial proarrhythmic effects of class 1c antiarrhythmic drugs. Am J Cardiol 1990;66:378-383.
16. Tai C-T, Chiang C-E, Lee S-H, et al: Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol 1999;10:1180-1187.
17. Huang DT, Monahan KM, Zimetbaum P, et al: Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9:462-469.
18. Emori T, Fukushima K, Saito H, et al: Atrial electrograms and activation sequences in the transition between atrial fibrillation and atrial flutter. J Cardiovasc Electrophysiol 1998;9:1173-1179.
19. Schumacher B, Jung W, Lewalter T, et al: Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999;83:710-713.
20. Nabar A, Rodriguez LM, Timmermans C, et al: Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol 1999;83:785-787.
21. Allessie MA, Lammers WJEP, Bonke FIM, et al: Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In Zipes DP, Jalife J, eds: Cardiac Arrhythmias. Grune & Stratton, Orlando, FL, 1985, pp. 265-275.
22. Feld GK, Fleck RP, Chen PS, et al: Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter: Identification of a critical zone in the re-entrant circuit by endocardial mapping techniques. Circulation 1992;86:1233-1240.
23. Garrey WE: The nature of fibrillatory contraction of the heart: Its relation to tissue mass and form. Am J Physiol 1914;33:397-414.
24. Rensma PL, Allessie MA, Lammers WJEP, et al: Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
25. Allessie MA, Bonke FIM, Schopman FJG: Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of non-uniform recovery of excitability in the occurrence of unidirectional block as studied with multiple microelectrodes. Circ Res 1976;39:168-177.
26. Wijffels MCEF, Kirchhof ATM, Dorland R, et al: Atrial fibrillation begets atrial fibrillation: A study in awake, chronically instrumented goats. Circulation 1995;92:1954-1968.
27. Ramdat Misier AR, Opthof T, van Hemel NM, et al: Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 1992;19:1531-1535.
28. Kumagai K, Akimitsu S, Kawahira K, et al: Electro-physiological properties in chronic lone atrial fibrillation. Circulation 1991;84:1662-1668.
29. Tieleman RG, Van Gelder IC, Crijns HJG, et al: Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:1676-1673.
30. Allessie MA, Lammers WJEP, Bonke FIM, et al: Intra-atrial reentry as a mechanism for atrial flutter induced by acetyleholine and rapid pacing in the dog. Circulation 1984;70:123-135.
31. Zipes DP, Michalick MJ, Robbins GT: Effects of selective vagal and stellate ganglion stimulation on atrial refractoriness. Cardiovasc Res 1974;8:647-655.
32. Cha YM, Wales A, Wolf P, et al: Electrophysiologic effects of the new class 3 antiarrhythmic drug dofetilide compared to the class 1a antiarrhythmic drug quinidine in experimental canine atrial flutter: Role of dispersion of refractoriness in antiarrhythmic efficacy. J Cardiovasc Electrophysiol 1996;7:809-827.
33. Feld GK, Cha YM: Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation. J Cardiovasc Pharmacol Ther 1997;2:195-204.
34. Feld GK, Mollerus M, Birgersdotter-Green U, et al: Conduction velocity in the tricuspid valve-inferior vena cava isthmus is slower in patients with a history of atrial flutter compared to those without atrial flutter. J Cardiovasc Electrophysiol 1997;8:1338-1348.
35. Feld GK, Venkatesh N, Singh BN: Pharmacologic conversion and suppression of experimental canine atrial flutter: Differing effects of d-sotalol, quinidine and lidocaine and the significance of changes in refractoriness and conduction. Circulation 1986;74:197-204.
36. Gallik DM, Kim SG, Ferrick KJ, et al: Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter. Am Heart J 1997;134:155-160.
37. Vos MA, Golitsyn SR, Stangl K, et al: Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998;79:568-575.
38. Ortiz J, Niwano S, Abe H, et al: Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res 1994;74:882-894.
39. Roithinger FX, Karch MR, Steiner PR, et al: Relationship between atrial fibrillation and typical atrial flutter in humans: Activation sequence changes during spontaneous conversion. Circulation 1997;96:3484-3491.
40. Chen PS, Pressley JC, Tang AS, et al: New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1992;19:974-981.
41. Tai C-T, Chen S-A, Chiang C-E, et al: Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: Risk prediction of recurrent arrhythmias. J Cardiovasc Electrophysiol 1998;2:115-121.